| | |
Reuters 01:32 PM | October 26,2009
Banks featured among the best performers. Banco Santander, Deutsche Bank, BNP Paribas and UniCredit were up 0.6 to 1.1%
|
|
Reuters 11:45 AM | October 24,2009
Sanofi said it has shipped 12 million of the 16.1 million vaccine doses the US government had received as of Friday
|
|
Ben Hirschler / Reuters 03:06 PM | October 06,2009
149 million doses ordered since August, total now 440 million; implies booked orders to date worth around $3.5 billion; discussions continue with governments for further supplies
|
|
Reuters 04:40 PM | September 23,2009
Weak dollar underpins commodity gains; Liberty leads property stocks lower after share placing; British data mixed but investors await Fed decision
|
|
Radhieka Pandeya 11:59 PM | May 25,2009
Ranbaxy is also slated to start formulating a significant portion of AstraZeneca’s US supply of Nexium from May 2010
|
|
Reuters 02:47 PM | May 05,2009
The Indian drug firm will also receive milestone payments and royalties from AstraZeneca on successful sale of any drug
|
|
Lison Joseph 10:17 PM | December 21,2008
Government’s medicine procurement arm switches from branded medicine to generics by Dr Reddy’s
|
|
02:48 PM | July 17,2008
Committee to probe why regulator continued to approve medicines made by the company while questioning Ranbaxy’s manufacturing processes
|
|
Bhuma Shrivastava 11:03 PM | April 15,2008
The deal will help AstraZeneca stave off potential competition from Ranbaxy’s generic or off-patent offering
|
|
Chitra Narayanan 12:27 AM | March 25,2008
In India the biggest consequence of smoking is not cancer, but the risk of contracting TB
|
|
C.H.Unnikrishnan 12:48 AM | November 21,2007
Iressa is the third non-Indian drug brand to be turned down under relatively new Indian patent laws
|
|
Bhuma Shrivastava and C.H. Unnikrishnan 02:12 AM | August 08,2007
A large chunk of these have been filed by the local units of drug majors such as Merck, AstraZeneca and Pfizer
|
|